{"id":2511,"date":"2019-10-06T14:56:14","date_gmt":"2019-10-06T12:56:14","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=2511"},"modified":"2024-04-19T10:11:14","modified_gmt":"2024-04-19T08:11:14","slug":"infeccions-i-cancer","status":"publish","type":"page","link":"https:\/\/idibell.cat\/recerca\/area-de-cancer\/programa-depidemiologia-salut-publica-prevencio-del-cancer-i-cures-palliatives\/infeccions-i-cancer\/","title":{"rendered":"Infeccions i C\u00e0ncer"},"content":{"rendered":"\n

\n\t\tInfeccions i c\u00e0ncer\n\t<\/h1>\n

\n\t\tResum\n\t<\/h3>\n\t

El grup d’infeccions i c\u00e0ncer s’interessa per la lluita entre virus i hostes, des d’una perspectiva evolutiva: els mecanismes antivirals que els animals han desenvolupat i les estrat\u00e8gies antivirals que han incidit en la selecci\u00f3 dels virus. Investiguen la connexi\u00f3 entre infecci\u00f3 i c\u00e0ncer, exemplificada pel virus del papil\u00b7loma (HPV).<\/p>\n

925<\/h2>\n

Publicacions<\/h2>\n\t\t\t\t\"hpv_causing_cervical_cancer\"\n\t\t\t\t\tL\u00ednies estrat\u00e8giques<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tVirus del Papil\u00b7loma Hum\u00e0 (VPH) i c\u00e0ncer genital.
\nVPH i c\u00e0ncer d’es\u00f2fag, cavitat oral, pell, vagina, vulva, penis i anus.
\nVirus hepatotr\u00f2pics (Virus de la Hepatitis B i C – VHB, VHC) i c\u00e0ncer de fetge.
\nAssaigs de vacunaci\u00f3 VPH i estudis d’intervenci\u00f3 en la prevenci\u00f3 del c\u00e0ncer.
\nEtiologia infecciosa dels limfomes malignes.
\nCentre d’Informaci\u00f3 sobre VPH i c\u00e0ncer cervical de l’OMS\/ICO.
\nDesenvolupament d’instruments log\u00edstics de coordinaci\u00f3 i difusi\u00f3 d’informaci\u00f3 sobre virus i c\u00e0ncer.
\nCribratge i prevenci\u00f3 del c\u00e0ncer genital.
\nAvaluaci\u00f3 de tecnologies de detecci\u00f3 viral.
\nModelitzaci\u00f3 i avaluaci\u00f3 econ\u00f2mica de mesures de prevenci\u00f3 del c\u00e0ncer.\n\t\t\t\t\t
Publicacions seleccionades<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t

Kolijn PMM, Saberi Hosnijeh F, Sp\u00e4th F, Hengeveld PJ, Agathangelidis A, Saleh M, Casabonne D, Benavente Y, Jerkeman M, Agudo A, Barricarte A, Besson C, S\u00e1nchez MJ, Chirlaque MD, Masala G, Sacerdote C, Grioni S, Schluze M, Nieters A, Engelfriet P, Hultdin M, McKay JD, Vermeulen RCH, Langerak AW. HIGH-RISK SUBTYPES OF CHRONIC LYMPHOCYTIC LEUKEMIA ARE DETECTABLE AS EARLY AS 16 YEARS PRIOR TO DIAGNOSIS<\/strong>. Blood. 2022;139(10):1557-1563. doi:10.1182\/blood.2021012890.<\/p>\n

Watson Jones D, Changalucha J, Whitworth H, Pinto L, Mutani P, Indangasi J, Kemp T, Hashim R, Kamala B, Wiggins R, Songoro T, Connor N, Mbwanji G, Pavon MA, Lowe B, Mmbando D, Kapiga S, Mayaud P, de Sanjos\u00e9 S, Dillner J, Hayes RJ, Lacey CJ, Baisley K. Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS)<\/strong>: an open-label, randomised, non-inferiority trial. Lancet Glob. Health. 2022;10(10):1473-1484. doi:10.1016\/S2214-109X(22)00309-6.<\/p>\n

Herzog C, Mar\u00edn F, Jones A, Evans I, Reisel D, Redl E, Schreiberhuber L, Paytubi S, Pelegrina B, Carmona \u00c1, Peremiquel Trillas P, Frias Gomez J, Pineda M, Brunet J, Ponce J, Matias Guiu X, de Sanjos\u00e9 S, Alemany L, Olaitan A, Wong M, Jurkovic D, Crosbie EJ, Rosenthal AN, Bj\u00f8rge L, Zikan M, Dostalek L, Cibula D, Sundstr\u00f6m K, Dillner J, Costas L, Widschwendter M. A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case\/Control Sets<\/strong>. J. Clin. Oncol. 2022;40(33):3828-doi:10.1200\/JCO.22.00266.<\/p>\n

Paytubi S, Benavente Y, Montoliu A, Binefa G, Brotons M, Ibanez R, Ochoa C, Peremiquel Trillas P, Serrano B, Travier N, Alemany L, Costas L. Everything causes cancer? Beliefs and attitudes towards cancer prevention among anti-vaxxers, flat earthers, and reptilian conspiracists: online cross sectional survey<\/strong>. BMJ-British Medical Journal. 2022;379doi:10.1136\/bmj-2022-072561.<\/p>\n

Bruni L, Serrano B, Roura E, Alemany L, Cowan M, Herrero R, Poljak M, Murillo R, Broutet N, Riley LM, de Sanjose S. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis<\/strong>. Lancet Glob. Health. 2022;10(8):1115-1127.<\/p>\n\t\t\t\t\tProjectes seleccionats<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t

CEE21039. PERCH: PartnERship to Contrast HPV<\/strong>. COMISSI\u00d3 EUROPEA. Budget: 409468,03. 2022-2025. PI: Brotons Agull\u00f3, Maria.<\/p>\n

MCI22005. WOMEC ADVANCED : NUEVAS APROXIMACIONES PARA EL DIAGN\u00d3STICO DE C\u00c1NCER DE ENDOMETRIO<\/strong>. Ministerio de Ciencia e Innovaci\u00f3n. Budget: 194288. 2022-2025. PI: Costas Caudet, Laura.<\/p>\n

19CEE002. HEADSpAcE: Translational studies of HEAD and neck cancer in South America and Europe<\/strong>. COMISSI\u00d3 EUROPEA. Budget: 249985. 2019-2023. PI: Alemany Vilches, Laia.<\/p>\n

PNJ22019. Reduction of VIral InFectivity and Transmission in HPV positive women before and after vaccination with GARDASIL-9<\/strong>. The effect in oral and anal body fluids and after 1- or 2- vaccine doses (RIFT-HPV II)<\/strong>. MERCK SHARP & DOHME ESPA\u00d1A S.A.. Budget: 140478,25. 2021- . PI: Bosch Jos\u00e9, Francesc Xavier.<\/p>\n

FIS21057. Human papillomavirus protection index (HPV-PI)<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 47190. 2022-2024. PI: Bruni Coccoz, Laia.<\/p>\n\t\t\t\t\"Laia-Alemany22\"\n

\n\t\tAlemany Vilches, Maria Eulalia\n\t<\/h4>\n

\n\t\t\n\t\tmalemany@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tInvestigadors principals\n\t<\/h2>\n\t\t\t\t\"Laia-Alemany22\"\n

\n\t\tAlemany Vilches, Maria Eulalia\n\t<\/h4>\n

\n\t\t\n\t\tmalemany@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"delphine-casabonne\"\n

\n\t\tCasabonne, Delphine\n\t<\/h4>\n

\n\t\t\n\t\tdcasabonne@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Claudia-Robles-Hellin\"\n

\n\t\tRobles Hellin, Claudia\n\t<\/h4>\n

\n\t\t\n\t\tcrobles@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"bosch-jose-fcoJavier\"\n

\n\t\tBosch Jose, FcoJavier\n\t<\/h4>\n

\n\t\t\n\t\txbosch@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Raquel-Iba\u00f1ez\"\n

\n\t\tIb\u00e1\u00f1ez P\u00e9rez, Raquel\n\t<\/h4>\n

\n\t\t\n\t\tribanez@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Maria-Brotons-Agullo\"\n

\n\t\tBrotons Agull\u00f3, Maria\n\t<\/h4>\n

\n\t\t\n\t\tmbrotons@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Laia-Bruni22\"\n

\n\t\tBruni Coccoz, Laia\n\t<\/h4>\n

\n\t\t\n\t\tlbruni@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Mireia-Diaz-Sanchis\"\n

\n\t\tDiaz Sanchis, Mireia\n\t<\/h4>\n

\n\t\t\n\t\tmdiaz@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Miguel-\u00c1ngel-Pav\u00f3n-Ribas\"\n

\n\t\tPavon Ribas, Miquel Angel\n\t<\/h4>\n

\n\t\t\n\t\tmpavon@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Laura-Costas-Caudet\"\n

\n\t\tCostas Caudet, Laura\n\t<\/h4>\n

\n\t\t\n\t\tlcostas@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tENLLA\u00c7OS RELACIONATS\n\t<\/h4>\n

\n\t\t\n\t\tHPV CENTRE\n\t\t<\/a>\n\t<\/h4>\n

\n\t\t\n\t\t@MejorSinCancer\n\t\t<\/a>\n\t<\/h4>\n

\n\t\t\n\t\t@Laura_Costas_\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tEquip\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tCaps de grup\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es principals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es cl\u00ednics\/ques\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es postdoctorals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es predoctorals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tSuport cient\u00edfic\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tSuport de gesti\u00f3\t\t\t\t<\/a>\n\t\t\t\t\t\tCaps de grup\n\t\t\t\t\t\t\t\t\t\t\t